Report Detail
Global mRNA COVID-19 Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4744931 |
- 28 September, 2026 |
- Global |
- 72 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global mRNA COVID-19 Vaccine market size was valued at US$ 4318 million in 2025 and is forecast to a readjusted size of US$ 4712 million by 2032 with a CAGR of 1.3% during review period.
Messenger ribonucleic acid (mRNA) is a molecule that provides cells with instructions for making proteins. mRNA vaccines contain the instructions for making the SARS-CoV-2 spike protein. This protein is found on the surface of the virus that causes COVID-19. The mRNA molecule is essentially a recipe, telling the cells of the body how to make the spike protein. mRNA COVID-19 Vaccines are given by injection, usually into the muscle of the upper arm.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global mRNA COVID-19 Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global mRNA COVID-19 Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global mRNA COVID-19 Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global mRNA COVID-19 Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global mRNA COVID-19 Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for mRNA COVID-19 Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global mRNA COVID-19 Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, CanSino Biologicals, Pfizer, Fosun-Pharmaceutical, CSPC Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
mRNA COVID-19 Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Non-replicating mRNA Vaccine
Self-amplifying mRNA Vaccine
Market segment by Application
Children
Adults
Major players covered
Moderna
CanSino Biologicals
Pfizer
Fosun-Pharmaceutical
CSPC Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe mRNA COVID-19 Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of mRNA COVID-19 Vaccine, with price, sales quantity, revenue, and global market share of mRNA COVID-19 Vaccine from 2021 to 2026.
Chapter 3, the mRNA COVID-19 Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the mRNA COVID-19 Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and mRNA COVID-19 Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of mRNA COVID-19 Vaccine.
Chapter 14 and 15, to describe mRNA COVID-19 Vaccine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global mRNA COVID-19 Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Non-replicating mRNA Vaccine
- 1.3.3 Self-amplifying mRNA Vaccine
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global mRNA COVID-19 Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Children
- 1.4.3 Adults
- 1.5 Global mRNA COVID-19 Vaccine Market Size & Forecast
- 1.5.1 Global mRNA COVID-19 Vaccine Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global mRNA COVID-19 Vaccine Sales Quantity (2021-2032)
- 1.5.3 Global mRNA COVID-19 Vaccine Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Moderna
- 2.1.1 Moderna Details
- 2.1.2 Moderna Major Business
- 2.1.3 Moderna mRNA COVID-19 Vaccine Product and Services
- 2.1.4 Moderna mRNA COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Moderna Recent Developments/Updates
- 2.2 CanSino Biologicals
- 2.2.1 CanSino Biologicals Details
- 2.2.2 CanSino Biologicals Major Business
- 2.2.3 CanSino Biologicals mRNA COVID-19 Vaccine Product and Services
- 2.2.4 CanSino Biologicals mRNA COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 CanSino Biologicals Recent Developments/Updates
- 2.3 Pfizer
- 2.3.1 Pfizer Details
- 2.3.2 Pfizer Major Business
- 2.3.3 Pfizer mRNA COVID-19 Vaccine Product and Services
- 2.3.4 Pfizer mRNA COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Pfizer Recent Developments/Updates
- 2.4 Fosun-Pharmaceutical
- 2.4.1 Fosun-Pharmaceutical Details
- 2.4.2 Fosun-Pharmaceutical Major Business
- 2.4.3 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Product and Services
- 2.4.4 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Fosun-Pharmaceutical Recent Developments/Updates
- 2.5 CSPC Pharmaceutical
- 2.5.1 CSPC Pharmaceutical Details
- 2.5.2 CSPC Pharmaceutical Major Business
- 2.5.3 CSPC Pharmaceutical mRNA COVID-19 Vaccine Product and Services
- 2.5.4 CSPC Pharmaceutical mRNA COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 CSPC Pharmaceutical Recent Developments/Updates
3 Competitive Environment: mRNA COVID-19 Vaccine by Manufacturer
- 3.1 Global mRNA COVID-19 Vaccine Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global mRNA COVID-19 Vaccine Revenue by Manufacturer (2021-2026)
- 3.3 Global mRNA COVID-19 Vaccine Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of mRNA COVID-19 Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 mRNA COVID-19 Vaccine Manufacturer Market Share in 2025
- 3.4.3 Top 6 mRNA COVID-19 Vaccine Manufacturer Market Share in 2025
- 3.5 mRNA COVID-19 Vaccine Market: Overall Company Footprint Analysis
- 3.5.1 mRNA COVID-19 Vaccine Market: Region Footprint
- 3.5.2 mRNA COVID-19 Vaccine Market: Company Product Type Footprint
- 3.5.3 mRNA COVID-19 Vaccine Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global mRNA COVID-19 Vaccine Market Size by Region
- 4.1.1 Global mRNA COVID-19 Vaccine Sales Quantity by Region (2021-2032)
- 4.1.2 Global mRNA COVID-19 Vaccine Consumption Value by Region (2021-2032)
- 4.1.3 Global mRNA COVID-19 Vaccine Average Price by Region (2021-2032)
- 4.2 North America mRNA COVID-19 Vaccine Consumption Value (2021-2032)
- 4.3 Europe mRNA COVID-19 Vaccine Consumption Value (2021-2032)
- 4.4 Asia-Pacific mRNA COVID-19 Vaccine Consumption Value (2021-2032)
- 4.5 South America mRNA COVID-19 Vaccine Consumption Value (2021-2032)
- 4.6 Middle East & Africa mRNA COVID-19 Vaccine Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global mRNA COVID-19 Vaccine Sales Quantity by Type (2021-2032)
- 5.2 Global mRNA COVID-19 Vaccine Consumption Value by Type (2021-2032)
- 5.3 Global mRNA COVID-19 Vaccine Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global mRNA COVID-19 Vaccine Sales Quantity by Application (2021-2032)
- 6.2 Global mRNA COVID-19 Vaccine Consumption Value by Application (2021-2032)
- 6.3 Global mRNA COVID-19 Vaccine Average Price by Application (2021-2032)
7 North America
- 7.1 North America mRNA COVID-19 Vaccine Sales Quantity by Type (2021-2032)
- 7.2 North America mRNA COVID-19 Vaccine Sales Quantity by Application (2021-2032)
- 7.3 North America mRNA COVID-19 Vaccine Market Size by Country
- 7.3.1 North America mRNA COVID-19 Vaccine Sales Quantity by Country (2021-2032)
- 7.3.2 North America mRNA COVID-19 Vaccine Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe mRNA COVID-19 Vaccine Sales Quantity by Type (2021-2032)
- 8.2 Europe mRNA COVID-19 Vaccine Sales Quantity by Application (2021-2032)
- 8.3 Europe mRNA COVID-19 Vaccine Market Size by Country
- 8.3.1 Europe mRNA COVID-19 Vaccine Sales Quantity by Country (2021-2032)
- 8.3.2 Europe mRNA COVID-19 Vaccine Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific mRNA COVID-19 Vaccine Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific mRNA COVID-19 Vaccine Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific mRNA COVID-19 Vaccine Market Size by Region
- 9.3.1 Asia-Pacific mRNA COVID-19 Vaccine Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific mRNA COVID-19 Vaccine Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America mRNA COVID-19 Vaccine Sales Quantity by Type (2021-2032)
- 10.2 South America mRNA COVID-19 Vaccine Sales Quantity by Application (2021-2032)
- 10.3 South America mRNA COVID-19 Vaccine Market Size by Country
- 10.3.1 South America mRNA COVID-19 Vaccine Sales Quantity by Country (2021-2032)
- 10.3.2 South America mRNA COVID-19 Vaccine Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa mRNA COVID-19 Vaccine Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa mRNA COVID-19 Vaccine Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa mRNA COVID-19 Vaccine Market Size by Country
- 11.3.1 Middle East & Africa mRNA COVID-19 Vaccine Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa mRNA COVID-19 Vaccine Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 mRNA COVID-19 Vaccine Market Drivers
- 12.2 mRNA COVID-19 Vaccine Market Restraints
- 12.3 mRNA COVID-19 Vaccine Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of mRNA COVID-19 Vaccine and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of mRNA COVID-19 Vaccine
- 13.3 mRNA COVID-19 Vaccine Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 mRNA COVID-19 Vaccine Typical Distributors
- 14.3 mRNA COVID-19 Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on mRNA COVID-19 Vaccine. Industry analysis & Market Report on mRNA COVID-19 Vaccine is a syndicated market report, published as Global mRNA COVID-19 Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of mRNA COVID-19 Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
